Omeros Corporation (OMER) earnings
OMER earnings moved a median of +4.21% by the close. Quarterly and annual OMER reports and results, each read against the price at its own news timestamp. Back to the OMER overview →
20 measured OMER earnings events.
Where these OMER earnings landedvs 20 measured OMER earnings reactions
| Middle 50% of OMER earnings reactions | -6.44% to +5.02% |
|---|---|
| Median reaction (to close) | +4.21% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 OMER earnings events with a measured close landed between -6.44% and +5.02%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q OMEROS CORP For: Jun 30 | SEC filing · Form 10-Q | +7.19% | +4.77% | |
| Omeros Corporation Reports Second Quarter 2026 Financial Results | Press release | +7.19% | +4.77% | |
| Form 10-Q OMEROS CORP For: Mar 31 | SEC filing · Form 10-Q | -9.51% | -9.78% | |
| Omeros Corporation Reports First Quarter 2026 Financial Results | Press release | -9.51% | -9.78% | |
| Form 10-K OMEROS CORP For: Dec 31 | SEC filing · Form 10-K | +8.39% | +6.71% | |
| Form 10-Q OMEROS CORP For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +4.25% | |
| Omeros Corporation Reports Second Quarter 2025 Financial Results | Press release | +0.00% | +4.25% | |
| Form 10-Q OMEROS CORP For: Mar 31 | SEC filing · Form 10-Q | -5.13% | -17.56% | |
| Omeros Corporation Reports First Quarter 2025 Financial Results | Press release | -5.13% | -17.56% | |
| Form 10-K/A OMEROS CORP For: Dec 31 | SEC filing · Form 10-K | -2.48% | -4.75% | |
| Form 10-K OMEROS CORP For: Dec 31 | SEC filing · Form 10-K | -7.31% | -13.65% | |
| Form 10-Q OMEROS CORP For: Sep 30 | SEC filing · Form 10-Q | +11.99% | +57.24% | |
| Omeros Corporation Reports Third Quarter 2024 Financial Results | Press release | +11.99% | +57.24% | |
| Form 10-Q OMEROS CORP For: Jun 30 | SEC filing · Form 10-Q | +2.42% | -5.33% | |
| Omeros Corporation Reports Second Quarter 2024 Financial Results | Press release | +2.42% | -5.33% | |
| Form 10-Q OMEROS CORP For: Mar 31 | SEC filing · Form 10-Q | +1.28% | +5.75% | |
| Omeros Corporation Reports First Quarter 2024 Financial Results | Press release | +1.28% | +5.75% | |
| Form 10-K OMEROS CORP For: Dec 31 | SEC filing · Form 10-K | -7.53% | +4.45% | |
| Form 10-Q OMEROS CORP For: Sep 30 | SEC filing · Form 10-Q | -2.58% | +4.17% | |
| Omeros Corporation Reports Third Quarter 2023 Financial Results | Press release | -2.58% | +4.17% |
Keep exploring
More OMER: analyst actions → · SEC filings → · OMER overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Catalent, Inc. (CTLT) | 232 | +0.10% | 62% |
| Dyadic International, Inc. (DYAI) | 232 | 0.00% | 45% |
| SANUWAVE Health, Inc. (SNWV) | 232 | 0.00% | 49% |
| Bio-Rad Laboratories, Inc. Class A (BIO) | 231 | -0.06% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.